Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Louise Carstam
Observed names:
Carstam, Louise,
L Carstam,
L. Carstam
Institutions:
Sahlgrenska University Hospital,
Region Västra Götaland,
University of Gothenburg
Observed institutions:
Uppsala University,
Karolinska University Hospital,
Sahlgrenska University Hospital,
Copenhagen University Hospital,
Rigshospitalet,
Karolinska Institutet,
Region Västra Götaland,
St Olav's University Hospital,
University of Gothenburg
show all 9
ORCID:
0000-0001-6597-2570
Observed ORCID:
0000-0001-6597-2570
OpenAlex ID:
A5008374041
Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial
2023
·
Katja Werlenius
, Sara Kinhult
, et al.
·
JAMA Network Open
·
82
PDF
Return to work following diagnosis of low-grade glioma: A nationwide matched cohort study
2020
·
Isabelle Rydén
, Louise Carstam
, et al.
·
Neurology
·
59
PDF
The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study
2020
·
Alba Corell
, Sandra Ferreyra Vega
, et al.
·
BMC Cancer
·
59
PDF
Supporting clinical decision making in advanced melanoma by preclinical testing in personalized immune-humanized xenograft mouse models
2020
·
L. Ny
, L.Y. Rizzo
, et al.
·
Annals of Oncology
·
50
PDF
WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
2022
·
Louise Carstam
, Alba Corell
, et al.
·
Frontiers in Oncology
·
46
Age and surgical outcome of low-grade glioma in Sweden
2018
·
A. Corell
, L. Carstam
, et al.
·
Acta Neurologica Scandinavica
·
45
PDF
A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma
2018
·
Berglind O. Einarsdottir
, Joakim Karlsson
, et al.
·
Cell Death and Disease
·
43
PDF
Long-term follow up of patients with WHO grade 2 oligodendroglioma
2023
·
Louise Carstam
, Francesco Latini
, et al.
·
Journal of Neuro-Oncology
·
37
PDF
Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial
2018
·
Asgeir Store Jakola
, Katja Werlenius
, et al.
·
F1000Research
·
35
PDF
Post-surgical effects on language in patients with presumed low-grade glioma
2017
·
M. Antonsson
, A. Jakola
, et al.
·
Acta Neurologica Scandinavica
·
33
PDF
Socioeconomic factors affect treatment delivery for patients with low grade glioma: a Swedish population-based study
2019
·
Louise Carstam
, Isabelle Rydén
, et al.
·
Journal of Neuro-Oncology
·
28
PDF
Psychotropic and anti-epileptic drug use, before and after surgery, among patients with low-grade glioma: a nationwide matched cohort study
2021
·
Isabelle Rydén
, Erik Thurin
, et al.
·
BMC Cancer
·
17
PDF
Seizures in patients with IDH-mutated lower grade gliomas
2022
·
Louise Carstam
, Isabelle Rydén
, et al.
·
Journal of Neuro-Oncology
·
16
PDF
Circulating Brain Injury Biomarkers: A Novel Method for Quantification of the Impact on the Brain After Tumor Surgery
2023
·
Isak Michaëlsson
, Tobias Hallén
, et al.
·
Neurosurgery
·
15
PDF
Neurosurgical patterns of care for diffuse low-grade gliomas in Sweden between 2005 and 2015
2018
·
Louise Carstam
, Anja Smits
, et al.
·
Neuro-Oncology Practice
·
11
PDF
Global health status and fatigue score in isocitrate dehydrogenase-mutant diffuse glioma grades 2 and 3: A longitudinal population-based study from surgery to 12-month follow-up
2024
·
Tomás Gómez Vecchio
, Isabelle Rydén
, et al.
·
Neuro-Oncology Practice
·
7
PDF
Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year period
2022
·
Caroline Svenjeby
, Louise Carstam
, et al.
·
Journal of Neuro-Oncology
·
7
PDF
CDKN2A/B status versus morphology in diagnosing WHO grade 4 IDH-mutated astrocytomas: what is the clinical relevance?
2025
·
Anna Lipatnikova
, Teresia Kling
, et al.
·
Journal of Neuro-Oncology
·
5
PDF
Survival prediction with radiomics for patients with IDH mutated lower-grade glioma
2025
·
Alice Neimantaite
, Louise Carstam
, et al.
·
Journal of Neuro-Oncology
·
4
Stereoelectroencephalography for drug resistant epilepsy: precision and complications in stepwise improvement of frameless implantation
2025
·
Tatjana Liakina
, Andreas Bartley
, et al.
·
Acta Neurochirurgica
·
3
Contribution of cognitive function and fatigue to health-related quality of life in patients with IDH -mutant gliomas from diagnosis to long-term follow-up
2026
·
Isabelle Rydén
, Dongni Buvarp
, et al.
·
Neuro-Oncology Practice
·
2
Hemizygous deletion of CDKN2A/B in IDH -mutated glioma: Prognostic impact when adjusting for clinical factors
2026
·
Anna Lipatnikova
, Franziska M Ippen
, et al.
·
Neuro-Oncology Advances
·
2
Reliable cognitive changes the first year following guideline-based treatment of isocitrate dehydrogenase mutated gliomas: A longitudinal multicenter study
2025
·
Isabelle Rydén
, Francesco Latini
, et al.
·
Neuro-Oncology
·
2
PDF
Antisecretory factor for treatment of peritumoral edema in glioblastoma patients
2025
·
Louise Carstam
, Tomás Gómez Vecchio
, et al.
·
Acta Neurochirurgica
·
2
Corrigendum to ‘Supporting clinical decision making in advanced melanoma by preclinical testing in personalized immune-humanized xenograft mouse models’
2020
·
L. Ny
, L.Y. Rizzo
, et al.
·
Annals of Oncology
·
2
Show more works
View as search
Works count:
42
Citation count:
618
H-index:
14
I10-index:
15
Year
Topic
Type